Brief: Cleveland Biolabs Inc Qtrly Loss Per Share $0.04
14/11/2019 23:01
Nov 14 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS INC QTRLY LOSS PER SHARE $0.04
* CLEVELAND BIOLABS INC - AS OF SEPTEMBER 30, HAD $1.9
MILLION IN
CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS
* CLEVELAND BIOLABS INC - CURRENTLY, CASH EXPECTED TO FUND
OPERATIONS INTO SEPTEMBER 2020
Source text: (https://bit.ly/37g3qXo)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc